|
1.中華民國行政院衛生署。中華民國八十七年癌症登記報告。 2.吳明賢,林肇堂,李威傑等。台灣的胃癌。台灣醫誌1994; 93:s77-89. 3.Jones S, Henry W. Hippocrates. Cambridge, Harvard University Press, 1959 to 1962. 4.Aznavoorian S, Murphy AN. Molecular aspects of tumor cell invasion and metastasis. Cancer 1993; 71: 1368-1383. 5.Akiyama S, Yamada KM. Introduction: adhesion molecules in cancer. Part I. Seminars Cancer Biol 1993; 4: 215-218. 6.Monsky WL, Chen WT. Protease of cell adhesion proteins in cancer. Seminars Cancer Biol 1993; 4: 251-258. 7.Kubota S, Yamada Y. Cancer metastasis and basement membrane. Cell Technology 1992; 11(suppl. 1): s20-s24 (in Japanese). 8.Takeichi M. The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development 1988; 102: 639-655. 9.Pigott R, Power C. The Adhesion Molecule FactsBook. San Diego, USA. Academic Press, 1993. 10.Behrens J, Mareel MM, van Roy FM, Birchmeier W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 1989; 108: 2435-2447. 11.Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D, Birchmeier. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991; 113: 173-185. 12.Sekiguchi M, Sakakibara K, Fujii G. Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn J Exp Med 1978; 48: 61-68. 13.Taki T, Ishikawa H, Imai K, Yachi A, Matsumoto M. Immunological analysis of glycolipids on cell surfaces of cultured human tumor cell lines: expression of lactoneotetraosylceramide on tumor cell surface. J Biochem 1985; 98: 887-895. 14.King LD, Meng CL, Han SH, Ding MJ, Chang JM, Chen JK, Shen KL. Study of monoclonal antibody by Chinese gastric cancer cell lines (In Chinese). J Med Sci 1987; 8: 17-25. 15.Barranco SC, Townsend CM, Casartelli C JR, Macik BG, Burger NL, Boerwinkle WR and Gourley WK. Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res 1983; 43: 1703-1709. 16.Teicher BA, Kowal CD, Kennedy KA and Sartorelli AC. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res 1981; 41: 1096-1099. 17.Johnson J.P. Cell adhesion molecules of the immunoglobulin supergene family and their role in malignant transformation and progression to metastatic disease. Cancer Metast Rev 1991; 10: 11-22. 18.Weinel RJ, Rosendahl A, Neumann K, Chaloupka B, Erb D, Rothmund M, Santoso S. Expression and function of VLA-alpha 2, -alpha 3, -alpha 5 and -alpha 6-integrin receptors in pancreatic carcinoma. Int J Cancer 1992; 52: 827-833. 19.Anichini A, Mortarini R, Supino R, Parmiani G. Human melanoma cells with high susceptibility to cell-mediated lysis can be identified on the basis of ICAM-1 phenotype, VLA profile and invasive ability. Int J Cancer 1990; 46: 508-515. 20.Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacterophage T4. Nature(Lond.) 1970; 227: 680-685. 21.Dunn MJ. Gel Electrophoresis: proteins. Bios Scientific Publishers Limited, Oxford, UK. 1993. 22.Gamble JR, Vadas MA. A new assay for the measurement of the attachment of neutrophils and other cell types to endothelial cells. J Immunol Meth 1988; 109: 175-184. 23.Damsky CH, Richa J, Solter D, Knudsen K and Buck CA. Identification and purification of a cell surface glycoprotein mediating intercellular adhesion in embryonic and adult tissue. Cell 1983; 34: 455-466. 24.Wheelock MJ, Buch CA, Bechtol KB, Damsky CH. Soluble 80-kd fragment of cell-CAM 120/80 disrupts cell-cell adhesion. J Cell Biochem 1987; 34: 187-202. 25.Katayama M, Hirai S, Kamihagi K, Nakagawa K, Tasumoto M, Kato I. Soluble E-cadherin fragments increased in circulation of cancer patients. Br J Cancer 1994; 69: 580-555. 26.Koshikawa N, Yasumitsu H, Umeda M, Miyazaki K. Multiple secretion of matrix serine proteinases by human gastric carcinoma cell lines. Cancer Res 1992; 52: 5046-5053. 27.Akiyama S, Amo H, Watanabe T, Matsuyama M, Sakamoto J, Imaizumi M, Icgihashi H, Kondo T, Takagi H. Characteristics of three human gastric cancer cell lines, NU-GC-2, NU-GC-3 and NU-GC-4. Jpn J Surg 1988; 4: 438-446. 28.Stewart JR, Gibbs FA Jr. Hyperthermia in the treatment of cancer. Perspectives on its promise and its problems. Cancer 1984; 54: 2823-2830. 29.Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, Birchmeier W, Funke I. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 1993; 53: 1690-1695. 30.Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, Birchmeier W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 1991; 51: 6328-6337. 31.Shino Y, Watanabe A, Yamada Y, Tanase M, Yamada T, Matsuda M, Yamashita J, Tatsumi M, Miwa T, Nakano H. Clinicopathologic evaluation of immunohistochemical E-cadherin expression in human gastric carcinomas. Cancer 1995; 76: 2193-2201. 32.Hashimoto M, Niwa O, Nitta Y, Takeichi M, Yokoro K. Unstable expression of E-cadherin adhesion molecules in metastatic ovarian tumor cell. Jpn J Cancer Res 1989; 80: 459-463. 33.Takeichi M. Cadherin cell adhesion receptors as a morphogenic regulator. Science 1991; 251: 1451-1455. 34.Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HFM, Schaafsma HE, Debruyne FMJ, Isaacs WB. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 1992; 52: 5104-5109. 35.Matsuura K, Kawanishi J, Fujii S, Imamura M, Hirano S, Takeichi M, Niitsu Y. Altered expression of E-cadherin in gastric cancer tissues and carcinomatous fluid. Br J Cancer 1992; 66: 1122-1130. 36.Japanese Research Society of Gastric Cancer (JRSGC). Japanese classification of gastric carcinoma. Kanehara & Co., Ltd., Tokyo, 1995. 37.Hsieh MC, Wu CW, Lui WY, Chi CW. Construction of a computerized database for gastric cancer patients. Chin Med J(Taipei) 1990; 45: 26-33. 38.Sugarbaker PH. Indications. (In) Management of peritoneal surface malignancy using intraperitoneal chemotherapy and cytoreductive surgery. Manual for physicians and nurses. Michigan, The Ludann Company Grand Rapids, 3rd Ed., 1998: 13-20. 39.Coley WB. The treatment of malignant tumors by repeated inoculations of erysipelas with a report of ten original cases. Am J Med Sci 1893; 105: 487. 40.Loeb L. Tansplantation von Tumoren. Virchows Arch Pathol Anat Physiol 1903; 172: 345. 41.Perry M. The Chemotherapy Source Book. Baltimore, Williams & Wilkins Publishers, 1993. 42.Hornback NB. Historical aspects of hyperthermia in cancer therapy. Radiol Clinics of North America 1989; 27: 481. 43.Barlogie B, Corry PM, Drewinko B. In-vitro thermochemotherapy of human colon cancer cells with cis-dichloroammineplatinum (II) and mitomycin C. Cancer Res 1987; 40: 1165-1168. 44.Los G, Sminia P, Wondergem J. Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in rats. Eur J Cancer 1991; 27: 472-477. 45.Los G, van Vugt MJH, den Engelse L. Effects of temperature on the interaction of cisplatin and carboplatin with cellular DNA. Biochem Pharmacol 1993; 46: 1229-1237. 46.Los G, van Vugt MJH, Pinedo HM. Response of peritoneal solid tumors after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin. Br J Cancer 1994; 69: 235-241. 47.Trieb K, Sztankay A, Amberger A, Lechner H, Grubeck-Loebenstein B. Hyperthermia inhibits proliferation and stimulates the expression of differentiation markers in cultured thyroid carcinoma cells. Cancer Lett 1994; 87: 65-71. 48.Vaupel P, Kallinowski F. Physiological effects of hyperthermia. Rec Results Cancer Res 1987; 104: 71-109. 49.Vleminckx K, Vakaet L, Mareel M, Fiers W, Roy FV. Genetic manipulation of epithelial tumor cells reveals an invasion suppressor role. Cell 1991; 66: 107-119. 50.Hsieh MC, Wu CW, Lui WY, P’eng FK, Yu JL. Heat shock and cytokines modulate the expression of adhesion molecules on different human gastric cancer cell lines. Int J Cancer 1996; 67: 690-694. 51.Shimm DS, Gerner EW. Hyperthermia in the treatment of malignancies. (In) Therapeutic Heat and Cold. Justus Lehmann (Ed), Baltimore, Williams & Wilkins Publishers, 1990. 52.Raaphorst GP, Romano SL, Mitchell JB, Bedford JS, Dewey WC. Intrinsic differences in heat and /or x-ray sensitivity of seven mammalian cell lines cultured and treated under identical condition. Cancer Res 1979; 39: 396-341. 53.Graeber TG, Osmanian C, Jacks T, Houseman DE, Kock CJ, Lowe SW, Giaccia AJ. Hypoxia-mediated selection of cells with diminished apototic potential in solid tumor. Nature 1996; 379: 88-89. 54.Yonemura Y, Fujimura T, Fushida S, Takegawa S, Kamata T, Katayama K, Kosaka T, Yamaguchi A, Miwa K, Miyazaki I. Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg 1991; 15: 530-536. 55.Yonemura Y, Ninomiya I, Kaji M, Sugiyama K, Fujimura T, Sawa T, Katayama K, Tanaka S, Hirono Y, Miwa K, Miyazaki I. Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion positive gastric cancer. World J Surg 1995; 19: 450-455. 56.Gilly FN, Carry PY, Sayag AC. Regional chemotherapy (with mitomycin C) and intraoperative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterol 1994; 41: 124-129. 57.Hamazoe R, Maeta M, Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Cancer 1994; 73: 2048-2052. 58.Sayag AC, Gilly FN, Carry PY, Perdrix JP, Pantaix G, Brachet A, Banssillon V, Braillon G. Intraoperative chemohyperthermia in the management of digestive cancers. Oncol 1993; 50: 333-337. 59.Fujimoto S, Shresta D, Kokubun M, Kobayashi K, Kiuchi K, Takahashi M, Konno C, Ohota M, Koike S, Kitsukawa Y, Mizutani M, Okui K. Clinical trial with surgery and intraperitoneal hyperthermic perfusion for peritoneal recurrence of gastrointestinal cancer. Cancer 1989; 64: 154-157. 60.Fujimura T, Yonemura Y, Fushida S, Urade M, Takegawa S, Kamata T, Sugiyama K, Hasegawa H, Katayama K, Miwa K, Miyazaki I. Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. Cancer 1990; 65: 65-69. 61.Koga S, Hamazoe R, Maeta M, Shimizu N, Murakami A, Wakatsuki T. Prophylactic therapy for peritoneal recurrence of gastric cancer by contimuous hyperthermic peritoneal perfusion with mitomycin C. Cancer 1988; 61: 232-237. 62.Fujimura T, Yonemura Y, Maraoka K, Takamura H, Hirono Y, Sahara H, Ninomiya I, Matsumoto H, Tsugawa K, Nishimura G, Sugiyama K, Miwa K, Miyazaki I. Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer. Randomized controlled study. World J Surg 1994; 18: 150-155. 63.Sugarbaker PH. Principles. (In) Management of peritoneal surface malignancy using intraperitoneal chemotherapy and cytoreductive surgery. Manual for physicians and nurses. Michigan, The Ludann Company Grand Rapids, 3rd Ed., 1998: 6-8. 64.Gofuku J, Shiozaki H, Doki Y, Inoue M, Hirao M, Fukuchi N, Monden M. Characterization of soluble E-cadherin as a disease marker in gastric cancer patients. Br J Cancer 1998; 78: 1095-1101. 65.Schadendorf D, Diehl S, Zuberbier T, Schadendorf C, Henz BM. Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlates with clinical stage. Dermatology 1996; 192: 89-93. 66.Reinhardt KM, Steiner M, Zillig D, Nagel HR, Blann AD, Brinckmann W. Soluble intercellular adhesion molecule-1 in colorectal cancer and its relationship to acute phase proteins. Neoplasma 1996; 43: 65-67. 67.Banks RE, Gearing AJ, Hemingway IK, Norfolk DR, Perren TJ, Selby PJ. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer 1993; 68: 122-124. 68.Jung K, Lein M, Weiss S, Schnorr D, Henke W, Loening S. Soluble CD44 molecules in serum of patients with prostate cancer and benign prostatic hyperplasia. Eur J Cancer 1996; 4: 627-630. 69.Katayama M, Kurome T, Yamamoto K, Uchida H, Hino F, Kato I. Sandwich enzyme immunoassay for serum integrins using monoclonal antibodies. Clin Chim Acta 1991; 202: 179-190. 70.Brocks DG, Strecker H, Neubaur HP, Timpl R. Radioimmunoassay of laminin in serum and its application to cancer patients. Clin Chem 1986; 32: 787-791. 71.Katayama M, Kamihagi K, Hirai S, Kurome T, Murakami K, Hino F, Kato I. Urinary laminin fragments as a tumor marker potentially reflecting besement membrane destruction. Br J Cancer 1992; 65: 509-514. 72.Protheroe AS, Banks RE, Mzimba M, Porter WH, Southgate J, Singh PN, Bosomworth M, Harnden P, Smith PH, Whelan P, Selby PJ. Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer. Br J Cancer 1999; 80: 273-278. 73.Banks RE, Porter WH, Whelan P, Smith PH, Selby PJ. Soluble forms of the adhesion molecule E-cadherin in urine. J Clin Pathol 1995; 48: 179-180. 74.謝茂志。溫熱療法。(於)胃癌之診斷及治療。吳秋文, 雷永耀, 彭芳谷 主編。台北,九州圖書文物有限公司出版, 2000: 441-452. 75.Stephens AD, White SK, Belliveau JF, Bland RK, Esquivel J, Joyner JE, Steves MA, Stuart OA, Sugarbaker PH. Anesthiology for cytoreductive surgery and HIIC administration. (In) Hyperthermic intraoperative intraperitoneal chemotherapy. A multidisciplinary manual for perioperative staff. Washinton, D.C. Washinton Hospital Center Press, 1998: 8-13. 76.Paradies NE, Grunwald GB. Purification and characterization of NCAD90, a soluble endogenous form of N-cadherin, which is generated by proteolysis during retinal development and retains adhesive and neurite-promoting function. J Neurosci Res 1993; 36: 33-45. 77.Kawanishi J, Kato J, Sasaki K, Fujii S, Watanabe N, Nitsu Y. Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the b-catenin gene in a human cancer cell line, HSC-39. Mol Cell Biol 1995; 15: 1175-1181. 78.Jiang WG. E-cadherin and its associated protein catenins, cancer invasion and metastasis. Br J Surg 1996; 83: 437-446. 79.Shiozaki H, Kadowaki T, Dokey Y, et al. Effect of epidermal growth factor on cadherin-mediated adhesion in a human oesophageal cancer cell line. Br J Cancer 1995; 71: 250-258. 80.Hoschuetzky H, Aberle H, Kembler R. b-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. J Cell Biol 1994; 127: 1375-1380.
|